Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.8660
0.00 (0.00%)
Feb 27, 2026, 4:54 PM CET
Neola Medical AB Revenue
In the year 2025, Neola Medical AB had annual revenue of 8.28M SEK, down -18.13%. Neola Medical AB had revenue of 2.14M in the quarter ending December 31, 2025, a decrease of -2.95%.
Revenue
8.28M
Revenue Growth
-18.13%
P/S Ratio
8.15
Revenue / Employee
1.04M
Employees
8
Market Cap
67.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.28M | -1.83M | -18.13% |
| Dec 31, 2024 | 10.12M | 292.00K | 2.97% |
| Dec 31, 2023 | 9.83M | 82.00K | 0.84% |
| Dec 31, 2022 | 9.74M | -1.38M | -12.43% |
| Dec 31, 2021 | 11.13M | 8.20M | 280.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 489.70M |
| Arcoma AB | 130.80M |
| ScandiDos AB | 61.26M |
| SciBase Holding AB | 36.59M |
| Nosa Plugs AB | 24.12M |
| Episurf Medical AB | 20.20M |
| Iconovo AB | 14.53M |
| Luxbright AB | 13.75M |